2025
Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial
Sklepinski S, Deng Y, Swarna K, Herrin J, Polley E, Neumiller J, Galindo R, Umpierrez G, Ross J, Borah B, Maron B, Mickelsonb M, McCoy R. Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial. Diabetes Research And Clinical Practice 2025, 112910. PMID: 40983112, DOI: 10.1016/j.diabres.2025.112910.Peer-Reviewed Original ResearchAssociated with lower riskModerate cardiovascular riskAll-Cause MortalityClaims dataCardiovascular riskLower risk of MACECardiovascular outcomesRisk of MACEData of adultsInverse probabilityTarget trialsInverse probability of treatmentCardiovascular risk reductionProbability of treatmentType 2 diabetes mellitusType 2 diabetesReceptor agonistsEffects of GLP-1 receptor agonistsGlucagon-like peptide-1 receptor agonistsPeptide-1 receptor agonistsGLP-1 receptor agonistsRisk reductionMajor adverse cardiovascular eventsComposite major adverse cardiovascular eventsRandomized treatment assignment
2009
Effect of Supersaturated Oxygen Delivery on Infarct Size After Percutaneous Coronary Intervention in Acute Myocardial Infarction
Stone GW, Martin JL, de Boer MJ, Margheri M, Bramucci E, Blankenship JC, Metzger DC, Gibbons RJ, Lindsay BS, Weiner BH, Lansky AJ, Krucoff MW, Fahy M, Boscardin WJ. Effect of Supersaturated Oxygen Delivery on Infarct Size After Percutaneous Coronary Intervention in Acute Myocardial Infarction. Circulation Cardiovascular Interventions 2009, 2: 366-375. PMID: 20031745, DOI: 10.1161/circinterventions.108.840066.Peer-Reviewed Original ResearchConceptsST-segment elevation myocardial infarctionMajor adverse cardiovascular eventsElevation myocardial infarctionPercutaneous coronary interventionAdverse cardiovascular eventsAnterior ST-segment elevation myocardial infarctionInfarct sizeCoronary interventionMyocardial infarctionCardiovascular eventsLeft anteriorSymptom onsetLarge ST-segment elevation myocardial infarctionComposite major adverse cardiovascular eventsSestamibi single-photon emissionMedian infarct sizePosthoc subgroup analysisPrimary efficacy measureAcute myocardial infarctionPrimary safety measureSingle photon emissionNoninferior ratesTreat populationProtocol populationMulticenter trial
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply